#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15994	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2178	730.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1437	1437	C	914	C,T	827,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28702	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3515	813.7	0	.	n	.	0	T695C	SNP	695	695	T	1032	1032	C	858	C,T	785,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28702	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3515	813.7	0	.	n	.	0	A1638G	SNP	1638	1638	A	1975	1975	G	897	G,A	814,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28702	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3515	813.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2308	2308	C	952	C	867	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28702	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3515	813.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2382	2382	A	984	A	912	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28702	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3515	813.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2934	2934	C	893	C	834	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2270	folP	855	855	100.0	folP.l6.c4.ctg.1	1431	157.8	1	SNP	p	R229S	1	.	.	685	687	AGC	971	973	AGC	206;207;206	A;G;C	192;192;188	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5754	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3395	169.1	1	SNP	p	S91F	1	.	.	271	273	TTC	570	572	TTC	192;187;187	T;T;C	181;176;174	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5754	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3395	169.1	1	SNP	p	D95G	1	.	.	283	285	GGC	582	584	GGC	191;188;187	G;G;C	179;175;172	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5754	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3395	169.1	1	SNP	p	G95N	0	.	.	283	285	GGC	582	584	GGC	191;188;187	G;G;C	179;175;172	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1768	mtrR	633	633	99.84	mtrR.l15.c30.ctg.1	1314	133.6	0	.	p	.	0	F184L	NONSYN	550	552	TTC	897	899	TTG	206;203;203	T;T;G	189;189;188	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1768	mtrR	633	633	99.84	mtrR.l15.c30.ctg.1	1314	133.6	1	SNP	p	G45D	0	.	.	133	135	GGC	480	482	GGC	231;229;231	G;G;C	204;201;205	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	868	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1055	82.1	0	.	n	.	0	A197.	DEL	197	197	A	576	576	A	208	A	191	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5402	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2899	185.8	1	SNP	p	D86N	0	.	.	256	258	GAC	511	513	GAC	229;227;231	G;A;C	208;202;211	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5402	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2899	185.8	1	SNP	p	R87W	0	.	.	259	261	CGT	514	516	CGT	232;229;231	C;G;T	213;208;210	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5402	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2899	185.8	1	SNP	p	R87I	0	.	.	259	261	CGT	514	516	CGT	232;229;231	C;G;T	213;208;210	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5402	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2899	185.8	1	SNP	p	S87R	1	.	.	259	261	CGT	514	516	CGT	232;229;231	C;G;T	213;208;210	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5402	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2899	185.8	1	SNP	p	S88P	0	.	.	262	264	TCC	517	519	TCC	230;232;230	TCC,TCCC;C;C	203,1;215;212	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4512	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2544	176.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1535	1537	GGC	212;211;211	G;G;C	192;189;191	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4524	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2431	185.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1271	1273	GCA	234;236;237	G;C;A	213;214;217	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4524	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2431	185.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1274	1276	ATC	237;234;237	A;T;C	216;214;216	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4524	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2431	185.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1286	1288	GTG	228;225;222	G;T;G	216;215;210	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4524	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2431	185.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1286	1288	GTG	228;225;222	G;T;G	216;215;210	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4524	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2431	185.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1790	1792	ACC	243;244;246	A;C;C	215;224;224	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4524	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2431	185.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1844	1846	GCG	252;249;248	G;C;G	217;194;198	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4524	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2431	185.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1844	1846	GCG	252;249;248	G;C;G	217;194;198	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4524	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2431	185.6	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1967	1969	AGC	218;215;212	A,G;G;C	196,1;192;193	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4524	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2431	185.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1976	1978	GGC	204;201;203	G;G;C	186;182;181	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4524	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2431	185.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1994	1996	CCG	179;184;181	C,G;C;GCCC,GCCCC	126,13;133;115,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6088	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3058	198.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1639	1641	CCG	227;230;231	C;C;G,C	205;212;206,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2334	porA	1146	1146	99.91	porA.l15.c30.ctg.1	1942	119.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	589	589	C	154	C	134	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	450	porB1a	984	273	91.58	porB1a.l15.c30.ctg.1	469	47.9	0	.	p	.	0	T250S	NONSYN	748	750	ACC	100	102	AGC	75;73;72	A;G,C;C	69;66,2;69	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	450	porB1a	984	273	91.58	porB1a.l15.c30.ctg.1	469	47.9	0	.	p	.	0	A251V	NONSYN	751	753	GCG	103	105	GTG	74;74;76	G;T,C;G,A	70;69,1;70,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	450	porB1a	984	273	91.58	porB1a.l15.c30.ctg.1	469	47.9	0	.	p	.	0	S271T	NONSYN	811	813	TCG	163	165	ACT	125;125;125	A,T;C;T,G	105,1;107;106,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	450	porB1a	984	273	91.58	porB1a.l15.c30.ctg.1	469	47.9	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	169	171	GAT	108;104;102	G,T;A;T	94,1;92;91	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	450	porB1a	984	273	91.58	porB1a.l15.c30.ctg.1	469	47.9	0	.	p	.	0	D274S	NONSYN	820	822	GAT	172	174	AGT	103;102;102	A,G;G,A;T	90,1;89,1;90	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	450	porB1a	984	273	91.58	porB1a.l15.c30.ctg.1	469	47.9	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	181	183	TAC	103;102;102	T,C,A;A;C	89,1,1;90;91	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	450	porB1a	984	273	91.58	porB1a.l15.c30.ctg.1	469	47.9	0	.	p	.	0	R307E	NONSYN	919	921	AGA	271	273	GAA	23;22;22	G;A;A	23;22;22	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	450	porB1a	984	273	91.58	porB1a.l15.c30.ctg.1	469	47.9	0	.	p	.	0	T311A	NONSYN	931	933	ACA	283	285	GCA	22;23;23	G;C;A	21;23;23	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	450	porB1a	984	273	91.58	porB1a.l15.c30.ctg.1	469	47.9	0	.	p	.	0	E312D	NONSYN	934	936	GAA	286	288	GAC	23;23;22	G;A;C	23;22;22	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	450	porB1a	984	273	91.58	porB1a.l15.c30.ctg.1	469	47.9	0	.	p	.	0	F314I	NONSYN	940	942	TTC	292	294	ATC	23;23;23	A;T;C	22;21;23	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	450	porB1a	984	273	91.58	porB1a.l15.c30.ctg.1	469	47.9	0	.	p	.	0	A316S	NONSYN	946	948	GCG	298	300	TCG	23;23;23	T;C;G	21;23;23	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	450	porB1a	984	273	91.58	porB1a.l15.c30.ctg.1	469	47.9	0	.	p	.	0	V318A	NONSYN	952	954	GTC	304	306	GCC	22;22;21	G;C;C	21;21;21	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	450	porB1a	984	273	91.58	porB1a.l15.c30.ctg.1	469	47.9	0	.	p	.	0	G319S	NONSYN	955	957	GGC	307	309	AGC	21;21;20	A;G;C	20;21;19	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	450	porB1a	984	273	91.58	porB1a.l15.c30.ctg.1	469	47.9	0	.	p	.	0	G320A	NONSYN	958	960	GGT	310	312	GCC	20;19;19	G;C;C	20;18;18	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	450	porB1a	984	273	91.58	porB1a.l15.c30.ctg.1	469	47.9	0	.	p	.	0	G322V	NONSYN	964	966	GGT	316	318	GTT	18;18;18	G;T;T	18;18;18	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	450	porB1a	984	112	91.96	porB1a.l15.c30.ctg.2	508	35.0	0	.	p	.	0	M18T	NONSYN	52	54	ATG	398	400	ACG	92;91;85	A;C;G	82;83;80	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	450	porB1a	984	112	91.96	porB1a.l15.c30.ctg.2	508	35.0	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	440	442	CAA	34;32;29	C;A;A	32;30;27	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	450	porB1a	984	112	91.96	porB1a.l15.c30.ctg.2	508	35.0	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	446	448	TAC	22;21;21	T;A;C	22;21;21	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2824	porB1b	1041	1041	97.33	porB1b.l15.c4.ctg.1	1522	184.1	0	.	p	.	0	N134D	NONSYN	400	402	AAT	698	700	GAT	205;208;207	G;A;T	188;190;191	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2824	porB1b	1041	1041	97.33	porB1b.l15.c4.ctg.1	1522	184.1	0	.	p	.	0	G140K	NONSYN	418	420	GGA	716	718	AAA	206;209;207	A;A;A	185;190;189	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2824	porB1b	1041	1041	97.33	porB1b.l15.c4.ctg.1	1522	184.1	0	.	p	.	0	K143E	NONSYN	427	429	AAA	725	727	GAA	210;209;209	G;A;A	186;181;184	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2824	porB1b	1041	1041	97.33	porB1b.l15.c4.ctg.1	1522	184.1	0	.	p	.	0	V151A	NONSYN	451	453	GTA	749	751	GCA	222;225;226	G,C;C,G;A	195,1;198,1;201	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2824	porB1b	1041	1041	97.33	porB1b.l15.c4.ctg.1	1522	184.1	0	.	p	.	0	I209M	NONSYN	625	627	ATC	923	925	ATG	248;248;250	A;T;G	227;226;229	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2824	porB1b	1041	1041	97.33	porB1b.l15.c4.ctg.1	1522	184.1	0	.	p	.	0	Y212fs	FSHIFT	634	634	T	932	932	T	247	T	229	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2824	porB1b	1041	1041	97.33	porB1b.l15.c4.ctg.1	1522	184.1	1	SNP	p	G120K	1	.	.	358	360	AAG	656	658	AAG	225;225;221	A;A;G,C	211;213;209,1	porB1b.WHO_O_01976:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2824	porB1b	1041	1041	97.33	porB1b.l15.c4.ctg.1	1522	184.1	1	SNP	p	A121D	1	.	.	361	363	GAC	659	661	GAC	223;220;218	G;A;C	213;207;207	porB1b.WHO_O_01976:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2824	porB1b	1041	1041	97.33	porB1b.l15.c4.ctg.1	1522	184.1	1	SNP	p	D121N	0	.	.	361	363	GAC	659	661	GAC	223;220;218	G;A;C	213;207;207	porB1b.WHO_O_01976:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11214	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4817	232.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1178	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1065	110.1	1	SNP	p	V57M	1	.	.	169	171	ATG	555	557	ATG	253;253;254	A;T;G	235;232;232	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
